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Here we report successful thoracoscopic-assisted sclerotherapy of a large, prenatally diagnosed microcystic thoracoabdominal lymphatic malformation in a 3-month-old infant born at 38 weeks gestational
age. Compression of the inferior vena cava and aortic displacement was demonstrated on imaging.
Treatment options include medical management, percutaneous sclerotherapy, or surgical resection. The
latter options were complicated by the location of this lesion. Therefore, sclerotherapy under direct
visualization via thoracoscopy was performed with near resolution of the lesion after one treatment. This
is the ﬁrst description of treatment of a lymphatic malformation via this approach reported in the
literature.
Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
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1. Case description
A routine second trimester ultrasound at 20 weeks gestational
age disclosed a large posterior mediastinal mass in a male fetus
during an otherwise uncomplicated pregnancy. This was followed
by term delivery at 38 þ 1 weeks gestational age. Abdominal
ultrasound on day of life 1 conﬁrmed the presence of a large, well
circumscribed, “spongy” appearing mass in the posterior mediastinum (Fig. 1). Further characterization with MRI (Fig. 2a) and
contrast CT scan showed the mass to be in the left pleural space,
extending across the posterior mediastinum, and through the aortic
hiatus of the diaphragm into the retroperitoneum. The lesion displaced the aorta posteriorly and rightward, the esophagus anteriorly, and signiﬁcantly compressed the inferior vena cava. Lack of an
appreciable feeding artery or vein, or involvement of neural
foramina were additional ﬁndings most consistent with a microcystic lymphatic malformation.
The patient was asymptomatic without signs of infection,
venous congestion, or ascites. Additionally, there was no respiratory
or feeding difﬁculty noted and the patient was discharged with
close interval follow-up. A repeat ultrasound at 1 month of age
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conﬁrmed that the mass had not signiﬁcantly changed in size,
echotexture, or displacement of surrounding structures.
Although the patient remained asymptomatic, the compression
of the vena cava and displacement of the aorta by this lymphatic
malformation were concerning, as in the event of hemorrhage or
infection, compression by mass effect could potentially be lethal.
Resection was considered, but given the potential for a large chylothorax, enthusiasm for this as ﬁrst line treatment was limited.
The proximity of this lymphatic malformation to critical thoracoabdominal structures raised concern for iatrogenic injury during
percutaneous sclerotherapy. The decision was made to perform
sclerotherapy under thoracoscopic visualization with a plan for
resection if this was not successful.
The patient was given 25 mg/kg cefazolin in addition to 0.1 mg/
kg dexamethasone preoperatively to mitigate the risk of postoperative swelling and vascular occlusion. The operation was
performed via a left-sided thoracoscopic approach with the patient 45 up from prone. One 5 mm thoracoscopic port was placed
at the 6th intercostal space in the midaxillary line. After introduction of CO2 pneumothorax to 6 mm Hg, a thoracoscope was
introduced and the mass immediately identiﬁed in the posterior
mediastinum. A 22 gauge spinal needle was inserted directly
through the chest wall at the 8th intercostal space in the posterior
axillary line. Attempts to aspirate the lymphatic malformation
were unsuccessful, likely due to its microcystic nature. 30 mL of
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At his 2 and 4-week post-op follow-up appointments the patient
continued to do well. Follow-up MRI at 6 weeks post-op showed
signiﬁcant reduction in size of the lymphatic malformation as well
as resolution of the vascular compression and displacement,
without evidence of effusion or ascites (Fig. 2b). The parents elected
not to proceed with further schlerotherapy given the signiﬁcant
response.

2. Discussion

Fig. 1. Abdominal ultrasound on day of life 1 shows a heterogeneously microcystic
structure surrounding the aorta (blue arrow, with vascular ﬂow) and compressing the
retrohepatic vena cava (white arrow).

a doxycycline 10 mg/mL solution was added to 7 mL of 0.25%
bupivacaine. A total dose of 83 mg, or 11 mg/kg of the doxycycline
was administered intra-lesionally in 4 sites in 10 mL aliquots. An
8-French pigtail catheter was placed through the trocar site and
removed the following day. The patient tolerated the procedure
well, required no narcotics post operatively and began breastfeeding the night of surgery. He was discharged home after 36 h of
monitoring, doing well and without symptoms.

Congenital lymphatic malformations arise from dysembryogenesis of the lymphatic system in utero and include a wide array of
pathologic and clinical manifestations. Pathologically these can be
characterized as combined lymphovascular malformations, isolated
cystic malformations, and congenital lymphedema. Using the 2014
ISSVA classiﬁcation system, this patient’s lesion is most likely a
benign lymphatic malformation without additional syndromeassociated anomaly [1]. Isolated cystic lymphatic malformations are
further classiﬁed as macrocystic, microcystic, or combined.
The combined incidence of lymphatic anomalies and lymphedema in children is well less than 1%, roughly 0.14% by one report
though there is a paucity of literature addressing the true epidemiology of these lesions [2]. There is no male vs. female predilection, with ratio of approximately 1:1. Symptoms, complications,
and to some extent prognosis, are primarily related to anatomical
location and extent of involvement therein, with 45e52% occurring in head and neck, followed by axilla, mediastinum, retroperitoneum, and groin [3]. Large isolated thoracoabdominal

Fig. 2. Representative (a) pre and (b) post-sclerotherapy coronal and axial T2 fat suppressed MRI with contrast showing dramatic improvement after a single thoracoscopic-guided
injection of doxycycline.
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lymphatic malformations as described in the case above are
exceedingly rare [2,4].
Large cystic lesions are often diagnosed prenatally upon 2nd
trimester US, as in this case, and may inﬂuence the location and
timing of delivery. Still, the majority remain diagnosed at birth [3]. On
ultrasonography, chyle is typically anechoic or hypoechoic. MRI will
allow better visualization of deep anatomic extent, and will show
perivascular T2 hyperintensity surrounding the aorta or iliac vessels
[5,6]. Macrocystic lesions tend to show multiple septations on
ultrasound with cysts of varying size compared to microcystic lesions, which are more uniform appearing as in our patient’s case [3].
The natural history of lymphatic malformations rarely involves
spontaneous resolution, most tend to grow with the patient if not
intervened upon [3,7]. Unmanaged growth of lymphatic malformations carries risk for infection, internal hemorrhage, lymphatic
or chylous leak, with additional risk of ﬂow redirection or recurrence following operative intervention [3,8,9].
Therapeutic interventions vary depending on location, symptoms, and active or potential complications, with an increasing trend
toward nonoperative management up front using sclerotherapy or
medical management. Single agent medical management with
sirolimus shows the most promising results, used for various lymphovascular malformations, though this remains associated with
leukopenia and other systemic toxicities [10]. Percutaneous sclerotherapy remains the most commonly used non-surgical management technique for lymphatic malformations. Microcystic lesions are
less responsive to sclerotherapy than their macrocystic counterparts,
and may require additional laser ablation or surgery [3,11,12].
Doxycycline, bleomycin, and OK-432 are the most commonly used
agents, and may require multiple injections for maximal resolution
depending on lesion size and complexity [8,9,11e18].
Primary resection is often anatomically difﬁcult due to location,
proximity to critical structures, and lesions whose extent does not
respect fascial planes, further elevating their level of anatomic
complexity. For these reasons surgical resection may often be followed by leak, recurrence, or redirection of lymphatic congestion.
Preoperative considerations include whether resection is being
performed for functional compromise, cosmesis, or both, and to
what extent either will be improved by the initial procedure versus
a staged approach to resection [3].
The most common post-operative complications of large thoracoabdominal lymphatic malformations are re-accumulation, and
leak with chylothorax or chylous ascites, which carries signiﬁcant
potential morbidity in small infants [19]. Lymphatic malformations
often grow with associated ectatic veins, which may lead to spontaneous or traumatic internal hemorrhage. Infection, either iatrogenic or due transient bacteremia may prove difﬁcult to treat [3,18].
In this case, the decision to perform sclerotherapy under thoracoscopic guidance was made after considering the risks of all
treatment options, to include expectant management, in an
asymptomatic patient. As the response to one treatment resulted in
resolution of the compression of the great vessels, the parents
opted for close follow-up only after a single treatment. He has been
followed for several months and continues to well, without evidence of re-accumulation on ultrasound.

3. Conclusion
We present a case of successful management of a microcystic
posterior mediastinal and retroperitoneal lymphatic malformation
treated with a single dose of doxycycline sclerotherapy injected
under thoracoscopic guidance.
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